Open access · OA
via OpenAlex
Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease
C. E. W. Nogueira, Selma B. Souto, Eduardo Vinha, Daniel C. Braga, Davide Carvalho
HORMONES · 2013 · ▲ 19 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.14310/horm.2002.1436
- Canonical
- link ↗
- Fetched
- 2026-06-29 MST
Cite this
APA
Nogueira, C.E.W., Souto, S.B., Vinha, E., Braga, D.C., & Carvalho, D. (2013). Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease. <em>HORMONES</em>. https://doi.org/10.14310/horm.2002.1436
Vancouver
Nogueira CEW, Souto SB, Vinha E, Braga DC, Carvalho D. Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease. HORMONES. 2013. doi:10.14310/horm.2002.1436.
BibTeX
@article{c2013Oralgl,
title = {Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease},
author = {C. E. W. Nogueira and Selma B. Souto and Eduardo Vinha and Daniel C. Braga and Davide Carvalho},
journal = {HORMONES},
year = {2013},
doi = {10.14310/horm.2002.1436},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinica Chimica Acta 2020
Citation only
Bone, inflammation and chronic kidney disease
Kidney International 2017
Preprint · OA
The hallmarks of mitochondrial dysfunction in chronic kidney disease
Kidney International 2020
Preprint · CC-BY
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
World Journal of Diabetes 2015
Open access · CC-BY
Magnesium and type 2 diabetes
Frontiers in Endocrinology 2022
Open access · CC-BY
Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
Diabetic Medicine 2005
Open access · OA